Orsi Giricz

1.6k citations

23 papers · 567 indexed · h-index 11

Hematology top 10%
- Acute Myeloid Leukemia Research 6
Cancer Research
- Protease and Inhibitor Mechanisms 2
Oncology
- Cytokine Signaling Pathways and Interactions 2
- Chemokine receptors and signaling 2
- Peptidase Inhibition and Analysis 2
Molecular Biology
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 2
Immunology
- Immune cells in cancer 2

Co-authors: Paraic A. Kenny Amit Verma Gregg B. Fields Verónica Calvo Yiting Yu Tushar D. Bhagat Janelle L. Lauer‐Fields Carolina Schinke
Cited by: Hematology Cancer Research Oncology
Partner nations: United States United Kingdom Ukraine

In The Last Decade

Orsi Giricz

21 papers receiving 562 citations

Peers

Countries citing papers authored by Orsi Giricz

Since Specialization

Citations

This map shows the geographic impact of Orsi Giricz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orsi Giricz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orsi Giricz more than expected).

Fields of papers citing papers by Orsi Giricz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orsi Giricz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orsi Giricz. The network helps show where Orsi Giricz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Orsi Giricz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Orsi Giricz Line = papers co-authored together Orsi Giricz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION. Divij Verma,Orsi Giricz,Rachel Zeig‐Owens,Kith Pradhan,Yiyu Zou,David Goldfarb,Srabani Sahu,Sakshi Jasra,Susheian Kelly,Srinivas Aluri,Shanisha Gordon-Mitchell,Anna Nolan,Michael D. Weiden,Charles B. Hall,Aditi Shastri,Advaitha Madireddy,Michael R. Savona,Ulrich Steidl,David J. Prezant,Amit Verma	2023	0
2	Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster Rachel Zeig‐Owens,David G. Goldfarb,Benjamin J. Luft,Xiaohua Yang,Kazunori Murata,Lakshmi V. Ramanathan,Katie Thoren,Sital Doddi,Urvi A. Shah,Alexandra K. Mueller,Charles B. Hall,Orsi Giricz,Amit Verma,David J. Prezant,Ola Landgren	2022	2
3	Inhibitors of BRAF dimers using an allosteric site Xiomaris M. Cotto-Rios,Bogos Agianian,Nadege Gitego,Emmanouil Zacharioudakis,Orsi Giricz,Yang Wu,Yiyu Zou,Amit Verma,Poulikos I. Poulikakos,Evripidis Gavathiotis	2020	52
4	ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations Nora E. Rahmani,Nandini Ramachandra,Tushar D. Bhagat,Shanisha Gordon,Kith Pradhan,Bianca Rivera-Peña,Mohammad Hossein Kazemi,Orsi Giricz,Shahina B. Maqbool,Raul Olea,Hamid Dolatshad,Vickram Tittrea,Dharamveer Tatwavedi,Shalini Singh,Andrea Pellagatti,Jacqueline Boultwood,Amit Verma	2019	2
5	IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells Carolina Schinke,Orsi Giricz,Weijuan Li,Aditi Shastri,Shanisha Gordon,Laura Barreyro,Tushar D. Bhagat,Sanchari Bhattacharyya,Nandini Ramachandra,Matthias Bartenstein,Andrea Pellagatti,Jacqueline Boultwood,Amittha Wickrema,Yiting Yu,Britta Will,Wei Sheng,Ulrich Steidl,Amit Verma	2015	145
6	Text S1 - Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D Culture Ju Han,Hang Chang,Orsi Giricz,Genee Y. Lee,Frederick L. Baehner,Joe W. Gray,Mina J. Bissell,Paraic A. Kenny,Bahram Parvin	2015	44
7	Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival Caroline Y. Hu,Davoud Mohtat,Yiting Yu,Yi-An Ko,Niraj Shenoy,Sanchari Bhattacharya,María C. Izquierdo,Ae Seo Deok Park,Orsi Giricz,Nishanth Vallumsetla,Krishna Gundabolu,Kristin Ware,Tushar D. Bhagat,Masako Suzuki,James Pullman,X. Shirley Liu,John M. Greally,Katalin Suszták,Amit Verma	2014	55
8	Targeting chemokine pathways in esophageal adenocarcinoma Makardhwaj Shrivastava,Zulfiqar Hussain,Orsi Giricz,Niraj Shenoy,Rahul Polineni,Anirban Maitra,Amit Verma	2014	28
9	Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine Aditi Shastri,Carolina Schinke,Asya Varshavsky Yanovsky,Tushar D. Bhagat,Orsi Giricz,Laura Barreyro,Jacqueline Boultwood,Andrea Pellagati,Yiting Yu,Jennifer R. Brown,David A. Frank,Bhaskar C. Das,Suman Kambhampati,Britta Will,Ulrich Steidl,Amit Verma	2014	6
10	Myelodysplastic Syndrome Marrow Stroma Shows Widespread Aberrant Hypermethylation That Is Abrogated By Treatment with Dnmt Inhibitors Tushar D. Bhagat,Matthias Bartenstein,Yiting Yu,A. Mario Marcondes,Britta Will,Orsi Giricz,Davendra Sohal,Ioannis Mantzaris,Amittha Wickrema,Christine M. McMahon,Yeung Cecilia,John M. Greally,Siddhartha Mukherjee,Ulrich Steidl,H. Joachim Deeg,Amit Verma	2014	2
11	Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects Timothy G. Bowler,Matthias Bartenstein,Kerry Morrone,Mersedeh Rohanizadegan,Rachel Kessel,Lauren Hooda,Ishan Datt,Orsi Giricz,Tushar D. Bhagat,Bartlomiej Przychodzen,Simrit Parmar,Jonathan Gill,Yiting Yu,Jaroslaw P. Maciejewski,Ulrich Steidl,Amit Verma	2014	2
12	Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer Hazuki E. Miwa,Wade Koba,Eugene J. Fine,Orsi Giricz,Paraic A. Kenny,Pamela Stanley	2013	29
13	Abstract A54: TACE-regulated TGF-alpha shedding drives GRB7-dependent invasion in triple-negative breast cancer cell lines Verónica Calvo,Orsi Giricz,Paraic A. Kenny	2013	1
14	Abstract A26: Integrated epigenomic profiling reveals widespread demethylation in melanoma, and reveals aberrant CSF-1 receptor expression as a regulator of malignant growth and invasion inhibited by PLX3397 Yongkai Mo,Orsi Giricz,Caroline Hu,Kimberly B. Dahlman,Sanchari Bhattacharyya,Hoa Nguyen,Bernice Matusow,Tushar D. Bhagat,Yiting Yu,Rafe Shellooe,Elizabeth M. Burton,Gaston Habets,John M. Greally,Paraic A. Kenny,Jeffrey A. Sosman,Gideon Bollag,Brian L. West,Amit Verma	2013	0
15	TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion Orsi Giricz,Verónica Calvo,Esther A. Peterson,Christiane Abouzeid,Paraic A. Kenny	2013	30
16	Abstract 1504: Pancreatic cancer associated fibroblasts are characterized by widespread epigenetic reprogramming that leads to aberrant expression of druggable target CXCR4. Tushar D. Bhagat,Yanique Rattigan,Brijesh Patel,Strepell Mirte,Yiting Yu,Davendra Sohal,Matthias Bartenstein,Orsi Giricz,Shanisha Gordon,Nishanth Vallumsetla,Rahul Polineni,Meher Walia,Paraic A. Kenny,John M. Greally,Debabrata Banerjee,Anirban Maitra,Amit Verma	2013	1
17	Hsa‐miR‐375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity Orsi Giricz,Paul A. Reynolds,Andrew Ramnauth,Christina Liu,Tao Wang,Lesley Stead,Geoffrey Childs,Thomas E. Rohan,Nella Shapiro,Susan Fineberg,Paraic A. Kenny,Olivier Loudig	2011	61
18	GRB7 is required for triple-negative breast cancer cell invasion and survival Orsi Giricz,Verónica Calvo,Stephanie C. Pero,David N. Krag,Joseph A. Sparano,Paraic A. Kenny	2011	49
19	Comparison of metalloproteinase protein and activity profiling Orsi Giricz,Janelle Lauer,Gregg B. Fields	2010	9
20	The normalization of gene expression data in melanoma: Investigating the use of glyceraldehyde 3-phosphate dehydrogenase and 18S ribosomal RNA as internal reference genes for quantitative real-time PCR Orsi Giricz,Janelle L. Lauer‐Fields,Gregg B. Fields	2008	35

About Orsi Giricz

Orsi Giricz is a scholar working on Hematology, Oncology and Cancer Research, having authored 23 papers that have together received 567 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers), Cytokine Signaling Pathways and Interactions (2 papers), Chemokine receptors and signaling (2 papers), Peptidase Inhibition and Analysis (2 papers), Ubiquitin and proteasome pathways (2 papers), Immune cells in cancer (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Hematology (104 citations), Cancer Research (125 citations) and Oncology (172 citations). Orsi Giricz has collaborated with scholars based in United States, United Kingdom and Ukraine. Frequent co-authors include Paraic A. Kenny, Amit Verma, Gregg B. Fields, Verónica Calvo, Yiting Yu, Tushar D. Bhagat, Janelle L. Lauer‐Fields, Carolina Schinke, Ulrich Steidl and Laura Barreyro.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact